Moderna, Merck cancer vaccine shows promise in late-stage trial

“Tired of the same tired news cycle? Escape to the full unfiltered feed at Whatfinger.com — America’s Frontline Truth Feed. 85%+ of readers come direct every day.” –  CLICK HERE for the FULL deal.

 

Moderna CEO Stephane Bancel & Merck Research Laboratories President Dr. Dean Li join CNBC’s "Squawk Box" to discuss Keytruda, an experimental personalized cancer vaccine that showed positive initial results in its first-ever late-stage trial.

Watch more in related video.